Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
about
Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intakeSerotonin and insulin signaling team up to control growth in DrosophilaSerotonin regulates C. elegans fat and feeding through independent molecular mechanismsPharmacological targeting of the serotonergic system for the treatment of obesitySerotonin as a New Therapeutic Target for Diabetes Mellitus and ObesityPeripheral Serotonin: a New Player in Systemic Energy HomeostasisLoss of a neural AMP-activated kinase mimics the effects of elevated serotonin on fat, movement, and hormonal secretionsBeneficial Effects of UV-Radiation: Vitamin D and beyondPalatability Can Drive Feeding Independent of AgRP Neurons.The expression of platelet serotonin transporter (SERT) in human obesity.Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor functionCo-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose.Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 miceThe expanded biology of serotonin.Profiling hepatic microRNAs in zebrafish: fluoxetine exposure mimics a fasting response that targets AMP-activated protein kinase (AMPK)A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent kinase-5Dynamic 5-HT2C receptor editing in a mouse model of obesity.Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.Central serotonergic neurons activate and recruit thermogenic brown and beige fat and regulate glucose and lipid homeostasis.Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptorsSerotonin and the regulation of mammalian energy balance.Metabolite profiles during oral glucose challenge.C. elegans dauer formation and the molecular basis of plasticity.Maternal high-fat diet during lactation impairs thermogenic function of brown adipose tissue in offspring mice.Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice.Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis.Nutritional state influences Nociceptin/Orphanin FQ peptide receptor expression in the dorsal raphe nucleus.Unraveling the central proopiomelanocortin neural circuits.5-hydroxytryptamine medications for the treatment of obesity.Metabolomics in diabetes, a review.Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.Decreased serotonin transporter immunoreactivity in the human hypothalamic infundibular nucleus of overweight subjects.Gastric ghrelin, GOAT, leptin, and leptinR expression as well as peripheral serotonin are dysregulated in humans with obesity.P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions.Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney DiseaseMetabolic changes over the course of aging in a mouse model of tau deposition.Increased neuronal survival in the brainstem during liver injury: role of γ-aminobutyric acid and serotonin chitosan nanoparticles.Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.Association of variations in TPH1 and HTR2B with gestational weight gain and measures of obesity.
P2860
Q21134750-A46C0C38-46A9-40D7-A93E-593E7829C26AQ24644780-6687D2C6-F43D-41EA-A52F-F5139E849851Q24649629-6A989CDB-F732-4454-B813-B5777D429448Q24658013-1847C0E4-7B30-4E1C-BA59-F33C4642879BQ26749092-B275AF26-820B-4464-ABF2-1C9A65A2119BQ26775537-00A3F5C4-0C2C-4010-83DF-5512D74B7A84Q27315375-2F661BEE-82C8-41D3-83CC-03087DE55D23Q28079688-102001DE-8909-4814-ADAB-8E78069D988BQ30278852-C12C5AA5-7605-4288-A913-1CDFAA00698EQ33591380-A00EE9C4-AABF-4D49-8330-A66E5C485023Q33814354-4C3ABD2A-C669-4587-884D-72FBB99E9D6EQ33861870-9491454C-C687-436B-B64F-C9F9FCBBE6A1Q34203010-314A00FE-12CF-4C4B-80C9-89EFFE09DACFQ34985850-C7619BC9-7C7E-4BBC-AE68-5D720AB1D5CCQ34993925-3243C06F-7BB7-4850-906E-284B6044DBA8Q35154001-7E513CF8-C6D4-488C-86D6-2DB99ADED304Q35612479-3D893621-D911-45D9-A816-C27CBF99284FQ35842417-FBC6CC51-F73A-4A7F-B267-6A66CC43E13CQ35919864-0274C4A4-9BB6-4EF8-AB11-A65D19E89589Q36045572-F9C484FC-32BC-4FF5-A9DC-11C1C85D5846Q36509808-7360AD7D-312D-4A6A-A41A-3B7AB1A35A44Q36718579-607BC45C-6711-4F22-BA67-12BACFFB0303Q37031030-99C0C57C-6B6F-4C47-A1E6-83943F3272FBQ37245616-C95BB4D7-23F4-4613-9008-C0B9C9660262Q37298892-C9E37403-7382-4847-BCC7-3DDF42A97413Q37371469-22477852-81FB-4CFD-8CBE-4BCDFED748B2Q37384053-749B87CA-05A6-4D38-B0BD-B515626CBE87Q37441099-7A5B9EE5-D939-40D0-9C8E-5D40B6CD5E3CQ38084559-97F2BD15-6750-4E0C-884A-B3BB3E804C98Q38449992-257BFACD-3D8A-4485-8296-CC9087345748Q38736350-46E63DFC-124F-46B9-8F87-87FCAC391558Q39518263-8AC3993D-B94D-4260-BD64-D3F3E6ED4C9CQ39852735-3132708F-6621-4EA7-B265-CC056E7C3ED0Q40086315-C7D99616-7F28-4427-A4D9-24DB6C959693Q41348083-4F39F3DC-17A3-4CF2-836E-D16DD2FBE8A0Q41452150-756C5330-CA28-4F87-B0EE-2CF6F9338FECQ42578395-2D4331F2-009B-4CE4-B631-64DDC7EDAE80Q45760410-9C502D2D-2979-45B2-A4DB-7D2EEC4247B2Q46082607-E7FFAB8C-3F2E-4443-9C5F-CA882AAECAEAQ47361389-3201E6B2-9A29-464C-B025-86A657B4914C
P2860
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@ast
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@en
type
label
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@ast
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@en
prefLabel
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@ast
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@en
P1476
Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
@en
P2093
Daniel D Lam
P356
10.1017/S1462399407000245
P577
2007-02-22T00:00:00Z